GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Operating Margin %

BioDelivery Sciences International (FRA:BD5) Operating Margin % : 20.98% (As of Dec. 2021)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. BioDelivery Sciences International's Operating Income for the three months ended in Dec. 2021 was €8.0 Mil. BioDelivery Sciences International's Revenue for the three months ended in Dec. 2021 was €38.2 Mil. Therefore, BioDelivery Sciences International's Operating Margin % for the quarter that ended in Dec. 2021 was 20.98%.

The historical rank and industry rank for BioDelivery Sciences International's Operating Margin % or its related term are showing as below:

FRA:BD5' s Operating Margin % Range Over the Past 10 Years
Min: -496.67   Med: -44.98   Max: 22.27
Current: 22.27


FRA:BD5's Operating Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 6.065 vs FRA:BD5: 22.27

BioDelivery Sciences International's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

BioDelivery Sciences International's Operating Income for the three months ended in Dec. 2021 was €8.0 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2021 was €31.6 Mil.


BioDelivery Sciences International Operating Margin % Historical Data

The historical data trend for BioDelivery Sciences International's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Operating Margin % Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.46 -42.50 3.35 21.08 22.27

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.53 18.13 27.45 22.53 20.98

Competitive Comparison of BioDelivery Sciences International's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioDelivery Sciences International's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Operating Margin % distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Operating Margin % falls into.



BioDelivery Sciences International Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

BioDelivery Sciences International's Operating Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Operating Margin %=Operating Income (A: Dec. 2021 ) / Revenue (A: Dec. 2021 )
=32.855 / 147.532
=22.27 %

BioDelivery Sciences International's Operating Margin % for the quarter that ended in Dec. 2021 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2021 ) / Revenue (Q: Dec. 2021 )
=8.011 / 38.191
=20.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioDelivery Sciences International  (FRA:BD5) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


BioDelivery Sciences International Operating Margin % Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines